Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s innovative drug development initiative-Group 3 pulmonary hypertension

By sjmartinez • July 1, 2022

Nikkho SM, Richter MJ, Shen E, Abman SH, Antoniou K, Chung J, Fernandes P, Hassoun P, Lazarus HM, Olschewski H, Piccari L, Psotka M, Saggar R, Shlobin OA, Stockbridge N, Vitulo P, Vizza CD, Wort SJ, Nathan SD. Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension. Pulm Circ. 2022 Jul 1;12(3):e12127. doi: 10.1002/pul2.12127. PMID: 36016668; PMCID: PMC9395696.

Tags: Epidemiology, interstitial lung disease, prognosis, Publications, pulmonary hypertension, Pulmonary, Critical Care & Sleep Medicine, symptom assessment and management

ACR Appropriateness Criteria® Chronic Ankle Pain: Update 2025

Expert Panel on Musculoskeletal Imaging; Schonberger A, Bartolotta RJ, Ha AS, Aung T, Bateni CP, Behrens SB, Geannette CS, Laur O, Morris RW, Rajakrishnan D,[...]

Perioperative Best Practices and Delirium in Patients With Cognitive Impairment

Scharp D, Meyers K, Nadkarni G, Federman A, Sarkisian C, Levin MA, Perry S, Gownivaripally P, Egorova NN, Ouyang Y, Hofer I, Vacas S. Perioperative[...]

Human antibody repertoire among kidney donors with and without HIV

Zhu X, Morgenlander WR, Brown DM, Eby Y, Morsheimer M, Odim J, Bagnasco SM, Rana MM, Florman SS, Friedman-Moraco RJ, Stock PG, Gilbert AJ, Mehta[...]